Real-time index price for Nasdaq Composite (NASX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Automotive retailer Lithia Motors (NYSE:LAD) announced in Q4 CY2024, with sales up 20.2% year on year to $9.22 billion. Its ...

Despite slow sales, the housing market had signs of life in the fourth quarter. That could help the home listings site’s ...

For investors looking to mirror Buffett’s time-tested strategy, Sirius XM and VeriSign offer a compelling mix of fundamentals and growth potential, making them no-brainer buys for a well-diversified ...

U.S. auto giant Ford F released its fourth-quarter 2024 earnings last Wednesday. While the company’s EPS and revenues beat ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Quantum Computing will inevitably face fierce competition in the crowded quantum computing industry. Read why I rate QUBT ...

Wall Street analysts appeared to breathe a sigh of relief after Apple's (AAPL) first quarter earnings modestly beat analysts' forecasts and the company’s explanation of falling iPhone sales in ...

The big picture: Meta recently posted excellent sales in its VR division while ... and Samsung are expected to increase market competition, making R&D investments more critical for staying ahead.

Novartis forecasts further profit and sales growth this year after beating analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto.

Apple’s quarterly profits and revenue crept past Wall Street forecasts, despite lower iPhone sales as it faced mounting competition in China. The group on Thursday reported revenue of $124.3 ...